Faron Pharmaceuticals Oy (LON:FARN)‘s stock had its “buy” rating reaffirmed by equities research analysts at Panmure Gordon in a report issued on Wednesday.

Faron Pharmaceuticals Oy (LON FARN) opened at 700.00 on Wednesday. The firm has a 50-day moving average price of GBX 708.58 and a 200 day moving average price of GBX 634.94. The stock’s market cap is GBX 184.18 million. Faron Pharmaceuticals Oy has a 52-week low of GBX 245.00 and a 52-week high of GBX 825.00.

TRADEMARK VIOLATION NOTICE: “Faron Pharmaceuticals Oy (FARN) Stock Rating Reaffirmed by Panmure Gordon” was originally reported by Watch List News and is the property of of Watch List News. If you are accessing this news story on another domain, it was copied illegally and republished in violation of United States & international copyright legislation. The original version of this news story can be viewed at https://www.watchlistnews.com/faron-pharmaceuticals-oy-farn-stock-rating-reaffirmed-by-panmure-gordon/1535278.html.

Faron Pharmaceuticals Oy Company Profile

Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with Analyst Ratings Network's FREE daily email newsletter.